Introduction & Objective: Academic medical centers have identified disparities in access to diabetes technology among adults but pediatric population access is understudied. This analysis performed a self-assessment of potential inequities in access to diabetes technology at this medical center, including CGMs, insulin pumps, and insulin pens for pediatric patients.
Methods: This study analyzed deidentified EMR data using multivariable logistic regressions to determine the association of social determinants (age, sex, race-ethnicity, insurance, and neighborhood socioeconomic disadvantage) with technology use among pediatric patients (ages ≤18) with T1D.
Results: Of 332 patients with T1D seen at UVA Health in 2022, 229 accessed CGMs, 57 used pumps, and 115 used insulin pens. For CGMs, public insurance and uninsured status related to lesser use/access. Pens appear to be accessed more equitably. (See Figure 1.)
Conclusion: CGMs are by far the most utilized technology in this pediatric population, followed by pens. Barriers to pump usage in this population need to be better understood but this center's small sample size makes the extent of inequities in access unclear.
M. Hall: None. C. Rodriguez: None. M.G. Maloney: None. L. Gonder-Frederick: None.
Lomar Foundation
